05/27/2026 | Companies

AmbioPharm, API manufacturing, Astorg, biopharmaceuticals, biotech industry, BNP Paribas, Carlyle Group, CDMO, China pharmaceutical manufacturing, clinical peptide supply, commercial peptide production, contract development and manufacturing organization, CordenPharma, global peptide supply, hybrid peptide synthesis, LPPS, North Augusta facility, peptide API, peptide APIs, peptide commercialization, peptide drug development, peptide manufacturing, peptide medicines, peptide platform, pharmaceutical acquisition, pharmaceutical industry, pharmaceutical manufacturing, Shanghai manufacturing, SPPS, TAPS technology, U.S. peptide manufacturing